NAM, GI HOON,남기훈,YANG, YOO SOO,양유수,KIM, IN SAN,김인산,PARK, SEUNG YOON,박승윤
申请号：
KR1020170023734
公开号：
KR1018921540000B1
申请日:
2017.02.22
申请国别(地区):
KR
年份:
2018
代理人:
摘要：
Provided are a composition for enhancing an immune response and a method using the same according to an aspect of the present invention. Accordingly, an anti-cancer immune response is improved by a congenital immune response, an adaptive immune response, or a combination thereof, and can be effectively used for cancer immunotherapy. The composition includes a Rho-associated protein kinase (ROCK) inhibitor and one or more anti-cancer drugs selected from a group composed of doxorubicin, mitoxantrone, cyclophosphamide, bleomycin, epirubicin, oxaliplatin, paclitaxel, cetuximab, and panitumumab.일 양상에 따른 면역 반응 증강용 조성물 및 이를 이용한 방법을 제공한다. 이에 따르면, 선천성 면역 반응, 적응 면역 반응, 또는 이들의 조합에 의해 항암 면역 반응이 향상되고, 암 면역요법에 효과적으로 이용할 수 있다.
